Deca 200 mg/NPP 150 mg Deca 200 mg/NPP 150 mg
Dragon Pharma

Deca 200 mg/NPP 150 mg

Product Information Compound Details
Dragon Pharma
Active Formula Nandrolone Dual-Ester Blend
350 mg/mL
Nandrolone Decanoate 200 mg
Nandrolone Phenylpropionate 150 mg
Total Strength 350 mg/mL
Package 10 mL Vial 3,500 mg total labeled content
Form Oil-Based Injectable
Formula 2-Ester Nandrolone Blend
Drug Class Anabolic Androgenic Steroid (19-nor)
Manufacturer Dragon Pharma
Latest Laboratory Result 195.22 mg / 146.96 mg March 20, 2026 · 97.61% & 97.97% of label claim View
$181.00
Shipping :
International
U.S. Domestic
Product Overview

Deca 200 mg/NPP 150 mg by Dragon Pharma

Deca 200 mg/NPP 150 mg is an oil-based injectable blend of Nandrolone Decanoate and Nandrolone Phenylpropionate manufactured by Dragon Pharma and dosed at 350 mg/mL in a 10 mL vial.

Nandrolone Decanoate & Phenylpropionate Blend

Deca 200 mg/NPP 150 mg combines two esters of the 19-nor anabolic steroid nandrolone in a single injectable formulation: nandrolone decanoate (200 mg/mL) and nandrolone phenylpropionate (150 mg/mL). Nandrolone decanoate is an FDA-approved ester for the management of anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Nandrolone phenylpropionate is a shorter-acting nandrolone ester that targets the androgen receptor and is classified as an anabolic agent.

Each ester contributes distinct release characteristics to the blend. Nandrolone decanoate has a long half-life of approximately 15 days, providing sustained release over weeks. Nandrolone phenylpropionate has a shorter half-life of approximately 2-3 days, providing a more rapid onset of action. The combination is designed to deliver both a rapid initial effect and a prolonged anabolic environment. In non-medical bodybuilding contexts, nandrolone esters are commonly referenced for their ability to promote muscle mass gains, joint comfort, and recovery during bulking or off-season cycles.

Nandrolone differs structurally from testosterone by lacking a carbon-19 methyl group, which contributes to its relatively lower androgenic activity compared to testosterone. Both esters ultimately release the same active hormone, nandrolone. Nandrolone decanoate is classified as a Schedule III controlled substance under the Anabolic Steroids Control Act of 1990. Non-medical use of this blend falls outside approved indications and may carry significant health risks, including cardiovascular and hepatic complications.

Key Benefits of Deca 200 mg/NPP 150 mg

  • Dual-ester blend for both rapid onset and sustained release
  • Long-acting decanoate ester for extended anabolic environment
  • Short-acting phenylpropionate ester for faster initial effects
  • Commonly referenced for joint comfort and recovery support
  • MCT oil carrier for smooth injection
Carrier Oil

MCT Oil Formulation

Deca 200 mg/NPP 150 mg uses MCT oil as its carrier, providing an oil base for the dual-ester nandrolone blend. The 350 mg/mL total concentration delivers 200 mg of nandrolone decanoate and 150 mg of nandrolone phenylpropionate per mL.

Product Profile

Nandrolone Decanoate & Phenylpropionate Profile

Deca 200 mg/NPP 150 mg is a dual-ester blend combining two nandrolone preparations with different release profiles. The decanoate ester provides extended release, while the phenylpropionate ester provides a shorter, more rapid release.

Dual-Ester 19-nor Nandrolone Blend

Nandrolone is a 19-nortestosterone derivative that binds to the androgen receptor and is classified pharmacologically as an androgen and anabolic agent. The decanoate ester attached to the 17-beta hydroxyl group produces a long-acting depot formulation with a half-life of approximately 15 days. Pharmacokinetic studies in healthy men have demonstrated that nandrolone decanoate produces sustained plasma nandrolone concentrations with the most sustained suppression of endogenous testosterone and inhibin occurring after gluteal injection.

Nandrolone phenylpropionate is a shorter-acting ester with higher and earlier peak plasma concentrations compared to the decanoate ester. This ester targets the androgen receptor and is classified under the ATC code A14AB01 (nandrolone derivatives). The combination of both esters in a single formulation is designed to provide a rapid initial rise in nandrolone levels from the phenylpropionate component, followed by a sustained release from the decanoate component.

Nandrolone decanoate is indicated for the management of anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. It is also used in clinical settings for osteoporosis, where it acts as an inhibitor of bone resorption. Non-medical use for physique enhancement is not approved and carries significant risks.

Release Profile

Dual-Phase Nandrolone Release

The dual-ester design of Deca 200 mg/NPP 150 mg produces a two-phase release profile. The phenylpropionate component provides a relatively rapid rise in blood nandrolone levels, with earlier and higher peaks compared to the decanoate ester alone. The decanoate component then provides sustained release over approximately 15 days, maintaining elevated nandrolone levels for an extended period. In non-medical contexts, this blend is typically referenced as being administered once or twice per week.

Deca 200 mg/NPP 150 mg vs Other Dragon Pharma Preparations

Dragon Pharma offers individual nandrolone preparations for users who prefer to control each ester separately. The Deca 300 provides nandrolone decanoate at 300 mg/mL as a single-ester formulation, while NPP 150 provides nandrolone phenylpropionate at 150 mg/mL. The dual-ester blend in Deca 200 mg/NPP 150 mg combines both in a fixed ratio that cannot be adjusted without additional standalone products.

In non-medical bodybuilding contexts, nandrolone esters are frequently stacked with a testosterone base such as Cypionate 250. Aromatase inhibitors may be referenced when the testosterone component produces estrogenic effects. Nandrolone suppresses endogenous testosterone production, so a testosterone base is commonly referenced in non-medical cycles.

Laboratory Testing

Deca 200 mg/NPP 150 mg Lab Reports

Published laboratory reports for Deca 200 mg/NPP 150 mg are shown below with the test date, measured concentration and percentage of the product's label claim for each component.

Deca 200 mg/NPP 150 mg by Dragon Pharma lab report dated March 20, 2026 showing 195.22 mg and 146.96 mg View Report
March 20, 2026
Batch HDDN02
Measured Result 195.22 mg / 146.96 mg 97.61% & 97.97% of label claim
Label 200 mg / 150 mg
Difference -4.78 mg / -3.04 mg

Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.

Dosage & Usage

Deca 200 mg/NPP 150 mg Dosage & Usage

The information below is provided for educational reference only. Nandrolone decanoate is a prescription medication; medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications.

Typical Dosage Ranges

In medically supervised use, nandrolone decanoate is dosed at 100 to 200 mg per week for men and 50 to 100 mg per week for women, with therapy discontinued if no hematologic improvement is seen within the first six months. In non-medical bodybuilding contexts, nandrolone esters are commonly referenced in the range of 200–400 mg per week for general use, with experienced users sometimes referencing higher amounts. One reference guide lists 200-250 mg once per week as a common protocol. The 350 mg/mL concentration of Deca 200 mg/NPP 150 mg means that 1 mL provides 200 mg nandrolone decanoate and 150 mg nandrolone phenylpropionate.

Use Case Common Reference Range Injection Frequency
Medical (anemia of renal insufficiency) 100–200 mg / week (men) Per prescriber instructions
Bodybuilding (non-medical) 200–400 mg / week Once or twice weekly
Joint support (non-medical) Often 100–200 mg / week Once weekly

Stacking & Cycle Considerations

In non-medical bodybuilding contexts, nandrolone blends are frequently referenced alongside a testosterone base compound. Dragon Pharma's Cypionate 250 is commonly mentioned in this context. Nandrolone is also sometimes combined with oral compounds during bulking cycles. The dual-ester design of Deca 200 mg/NPP 150 mg provides both rapid and sustained release, which may be referenced as an advantage for maintaining stable blood levels.

Nandrolone decanoate has a long detection time and can suppress endogenous testosterone production. Cycle structure, duration, and recovery considerations should account for these characteristics. Because the blend contains two esters with different half-lives, clearance after the final injection takes several weeks.

Managing Side Effects

Nandrolone can suppress gonadotropic functions of the pituitary and may exert a direct effect upon the testis, leading to reduced sperm production and testicular atrophy. Sexual dysfunction is a recognized risk, particularly without appropriate management. Nandrolone decanoate has been reported to increase low-density lipoproteins and decrease high-density lipoproteins.

Nandrolone is not a 17-alpha-alkylated oral steroid and therefore is not considered hepatotoxic in the same manner as oral C17-alpha-alkylated compounds. However, peliosis hepatis and liver cell tumors have been reported in patients receiving androgenic anabolic steroid therapy. Blood pressure and cardiovascular markers should be monitored during use.

Post-Cycle Therapy (PCT)

After completing a cycle with Deca 200 mg/NPP 150 mg, post-cycle therapy is commonly recommended in non-medical contexts to help restore endogenous testosterone production. Because the blend contains the long-acting decanoate ester, PCT should begin approximately 2–3 weeks after the final injection to allow the ester to clear. Agents such as Clomid or Nolvadex are frequently referenced for this purpose. Bloodwork and, where possible, medical guidance can help inform recovery strategy.

Important

Individual Response Varies

Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.

Safety & Information

Nandrolone Decanoate & Phenylpropionate Safety Information

Nandrolone decanoate is a Schedule III controlled anabolic steroid that can affect hematologic, cardiovascular, hepatic and reproductive function. Nandrolone phenylpropionate is also a controlled substance. Medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring.

Important Safety Information

Nandrolone decanoate is indicated for the management of anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. It has not been shown to be safe and effective for the enhancement of athletic performance, and the FDA label states it should not be used for such purpose. Nandrolone decanoate injection is classified as a Schedule III controlled substance under the Anabolic Steroids Control Act of 1990.

Peliosis hepatis, a condition in which liver and sometimes splenic tissue is replaced with blood-filled cysts, has been reported in patients receiving androgenic anabolic steroid therapy. These cysts are sometimes present with minimal hepatic dysfunction, but at other times they have been associated with liver failure.

Important

Non-Medical Use

Use of nandrolone esters for bodybuilding or performance enhancement falls outside approved medical indications. Higher-than-physiologic exposure can increase the risk of serious adverse effects including cardiovascular, hepatic and endocrine complications.

Potential Adverse Effects

Anabolic steroids including nandrolone have been reported to increase low-density lipoproteins and decrease high-density lipoproteins. These changes may have a serious impact on the risk of atherosclerosis and coronary artery disease. Blood lipid changes known to be associated with increased risk of atherosclerosis are seen in patients treated with androgens and anabolic steroids.

Nandrolone suppresses gonadotropic functions of the pituitary and may exert a direct effect upon the testis, leading to inhibition of testicular function, testicular atrophy, oligospermia, and impotence. In women, virilization signs such as deepening of the voice, hirsutism, acne, and clitoromegaly may occur and can be irreversible if the drug is continued after symptoms appear.

Edema may occur occasionally with or without congestive heart failure. Cholestatic jaundice is associated with therapeutic use of anabolic and androgenic steroids. Caution is required in administering these agents to patients with cardiac, renal or hepatic disease.

Conditions Requiring Medical Evaluation

Anabolic steroids are contraindicated in certain circumstances. Contraindications include male patients with carcinoma of the prostate or breast, carcinoma of the breast in females with hypercalcemia, nephrosis, the nephrotic phase of nephritis, and pregnancy. Nandrolone decanoate should not be used to enhance physical appearance or athletic performance.

Caution is required in administering anabolic steroids to patients with cardiac, renal or hepatic disease. Existing medical conditions should be discussed with a qualified healthcare professional before nandrolone is considered.

Monitoring During Therapy

Medically supervised nandrolone decanoate therapy typically involves periodic laboratory monitoring. Hemoglobin and hematocrit should be checked periodically for polycythemia in patients receiving high doses. Serum lipids and high-density lipoprotein cholesterol should be determined periodically. Because of the hepatotoxicity associated with 17-alpha-alkylated anabolic steroids, liver function tests should be obtained periodically.

Laboratory testing of the product itself, such as the published potency reports shown in the Lab Reports tab, is separate from clinical monitoring of the person using the medication.

Product Care

Storage & Handling

Keep the vial securely stored and protected from conditions that could compromise the product or container. Store at controlled room temperature and protect from light. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.

Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.

Further Safety Information
Shipping & Authenticity

Shipping & Product Authenticity

Deca 200 mg/NPP 150 mg by Dragon Pharma is shipped in original manufacturer packaging with discreet, privacy-focused handling.

USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply

Discreet Delivery & Original Packaging

The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.

What to Expect

  • Orders are processed after payment confirmation
  • USA Domestic shipping is typically faster when local stock is selected
  • International orders include tracking, though update frequency may vary by destination
  • Multiple warehouses may result in separate shipments when applicable

Authenticity Verification

To verify your Deca 200 mg/NPP 150 mg product, use the security code on the vial label and cross-check it on the Dragon Pharma official site. Original Dragon Pharma packaging and batch-linked lab proof help reinforce product legitimacy.

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Deca 200 mg/NPP 150 mg Storage

Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.

Recommended Conditions

Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.

Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.

Quick Reference

Do & Don't

  • Do store at 15–25°C
  • Do keep in original packaging
  • Do inspect before each use
  • Don't freeze the vial
  • Don't expose to direct sunlight
  • Don't use if solution looks abnormal
Frequently Asked Questions

Deca 200 mg/NPP 150 mg FAQ

Answers to common questions about Deca 200 mg/NPP 150 mg, the dual-ester nandrolone blend, usage considerations, and product strength.

What is Deca 200 mg/NPP 150 mg used for?

Deca 200 mg/NPP 150 mg contains nandrolone decanoate and nandrolone phenylpropionate. Nandrolone decanoate is medically indicated for the management of anemia of renal insufficiency. In non-medical bodybuilding settings, this blend is commonly referenced for muscle mass gains, joint comfort, and recovery during bulking cycles, though such use falls outside approved indications.

How often should Deca 200 mg/NPP 150 mg be injected?

Because the blend contains both a long-acting decanoate ester and a shorter-acting phenylpropionate ester, it is typically referenced as being administered once or twice per week in non-medical contexts. The 350 mg/mL concentration means that 1 mL provides 200 mg nandrolone decanoate and 150 mg nandrolone phenylpropionate.

Does Deca 200 mg/NPP 150 mg require PCT?

In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after a nandrolone cycle to help restore endogenous testosterone production. Because the blend contains the long-acting decanoate ester, PCT should begin approximately 2-3 weeks after the final injection. Agents such as Clomid or Nolvadex are commonly referenced for this purpose.

What do nandrolone decanoate and phenylpropionate do?

Both esters release the same active hormone, nandrolone, which binds to the androgen receptor and promotes nitrogen retention and protein synthesis. The decanoate ester provides a long-acting depot with a half-life of approximately 15 days, while the phenylpropionate ester provides a shorter, more rapid release with higher and earlier peak plasma concentrations.

How long does Deca 200 mg/NPP 150 mg take to work?

Because of the dual-ester design, the phenylpropionate component provides a relatively rapid rise in nandrolone levels, while the decanoate component provides sustained release over weeks. In non-medical contexts, users commonly reference noticing effects on muscle fullness, strength, and joint comfort within the first 2-3 weeks of use.

Is Deca 200 mg/NPP 150 mg the best nandrolone blend?

There is no single blend that is universally best. Deca 200 mg/NPP 150 mg combines two nandrolone esters in a fixed ratio for both rapid and sustained release. The individual preparations Deca 300 (nandrolone decanoate) and NPP 150 (nandrolone phenylpropionate) are also referenced, allowing users to adjust the ratio of esters independently.

What is the difference between Deca 200/NPP 150 and Deca 300?

Deca 300 contains only nandrolone decanoate at 300 mg/mL, providing a single long-acting ester. Deca 200 mg/NPP 150 mg adds nandrolone phenylpropionate for a more rapid initial release alongside the sustained decanoate release. The dual-ester blend provides both rapid and prolonged nandrolone exposure.

Is 350 mg of Deca 200/NPP 150 a lot?

A milligram amount cannot be classified as appropriate or excessive without considering the specific context, individual response, and other factors. In non-medical bodybuilding contexts, nandrolone esters are commonly referenced in the 200-400 mg per week range. Such use falls outside approved indications and nandrolone is known for significant side effect potential, including suppression of endogenous testosterone production.

What strength is Deca 200 mg/NPP 150 mg?

Deca 200 mg/NPP 150 mg is labeled at 350 mg of total active compounds per mL, comprising 200 mg nandrolone decanoate and 150 mg nandrolone phenylpropionate per mL. It is supplied in a 10 mL vial, giving 3,500 mg of total labeled content per vial.

Is Deca 200 mg/NPP 150 mg lab tested?

Yes. A published laboratory report dated March 20, 2026 measured Deca 200 mg/NPP 150 mg at 195.22 mg nandrolone decanoate and 146.96 mg nandrolone phenylpropionate, equivalent to 97.61% and 97.97% of label claim respectively.

The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report and should not be interpreted as a measurement of every vial.

Can nandrolone be detected in drug tests?

Yes. Nandrolone and its esters are prohibited substances in sport and can be detected in urine for extended periods after use. Nandrolone decanoate has a particularly long detection time due to its long half-life of approximately 15 days. Athletes subject to drug testing should be aware that positive tests can result in sanctions.

No reviews found

Please log in to write Deca 200 mg/NPP 150 mg review.

Related Offers
Lab Tested
Domestic & International
Cypionat 250 mg
Dragon Pharma, Europe
Product Information Compound Details
Dragon Pharma
Active Substance Testosterone Cypionate Long-acting testosterone ester
250 mg/mL
Strength 250 mg/mL
Package 10 mL Vial 2,500 mg total labeled content
Form Oil-Based Injectable (MCT Oil)
Estimated Half-Life Approximately 8 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
Latest Laboratory Result 277.11 mg/mL March 20, 2026 · 110.84% of label claim View
$53.00
Lab Tested
Domestic & International
Deca 300 mg
Dragon Pharma, Europe
Product Information Compound Details
Dragon Pharma
Active Substance Nandrolone Decanoate Long-acting injectable anabolic steroid
300 mg/mL
Strength 300 mg/mL
Package 10 mL Vial 3,000 mg total labeled content
Form Oil-Based Injectable (MCT Oil)
Half-Life Approximately 6–15 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
Latest Laboratory Result 287.93 mg/mL May 16, 2024 · 95.98% of label claim View
$66.00
Lab Tested
Domestic & International
Sustanon 270 mg
Dragon Pharma, Europe
Product Information Compound Details
Dragon Pharma
Active Formula 5-Ester Testosterone Blend
270 mg/mL
Testosterone Acetate 20 mg
Testosterone Propionate 30 mg
Testosterone Phenylpropionate 60 mg
Testosterone Isocaproate 60 mg
Testosterone Decanoate 100 mg
Total Strength 270 mg/mL
Package 10 mL Vial 2,700 mg total labeled content
Form Oil-Based Injectable (MCT Oil)
Formula 5-Ester Testosterone Blend
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
Latest Laboratory Result 271.26 mg/mL March 25, 2026 · 100.47% of label claim View
$61.00
Lab Tested
Domestic & International
Testo Blend 350 mg
Dragon Pharma, Europe
Product Information Compound Details
Dragon Pharma
Active Formula 3-Ester Testosterone Blend
350 mg/mL
Testosterone Propionate 50 mg
Testosterone Cypionate 100 mg
Testosterone Enanthate 200 mg
Total Strength 350 mg/mL
Package 10 mL Vial 3,500 mg total labeled content
Form Oil-Based Injectable (MCT Oil)
Formula 3-Ester Testosterone Blend
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
Latest Laboratory Result 346.63 mg/mL March 25, 2026 · 99.04% of label claim View
$66.00

Add to Cart - Product(s)

Close Button
Empty

Total Cost: